Mirum Pharmaceuticals Inc

MIRM•NASDAQ•HEALTHCAREMarket data unavailable

Price is syncing

Reported smart-money activity is still available below.

1 month

+0.9%

price return

Year to date

+9.9%

price return

Recent earnings

2/4

quarters beat

Big funds

8

hold this stock

News tone

Bearish

4 articles, 7 days

Smart money

Filed positions and reported activity tied to this stock.

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$849.3M

C
Citadel
Ken Griffin · Q1 2026 13F
$97.2M
position
TS
Two Sigma
Q1 2026 13F
$71.6M
position
JS
Jim Simons
Q1 2026 13F
$53.8M
position
B
Balyasny
Dmitry Balyasny · Q1 2026 13F
$49.8M
position
P
Point72
Steven Cohen · Q1 2026 13F
$32.1M
position

Show all 8 holders

B
BlackRock
Q1 2026 13F
$355.3M
position
FL
FMR LLC
Q1 2026 13F
$181.6M
position
JC

Insiders

What insiders are doing

7 trades · 6 mo

Sold$7.1M

Sells (5)

PC
Peetz Christopher
Chief Executive Officer · Cluster · Jul 8
$2.4M
sold
BE
Bjerkholt Eric
Chief Financial Officer · Cluster · Jul 8
$611K
sold

Checking federal contract awards

Coverage gaps for MIRMNo recent market-voice mention

News

Recent coverage and its overall tone.

News

What the news says

4 articles · 7 days

Coverage is bearish

0 bullish · 2 neutral · 2 bearish

Tone of tracked coverage

Mirum Pharmaceuticals (MIRM) Stock Looks Fully Valued On Current Sales Expectations
Leans bearishJul 23
Why (MIRM) Price Action Is Critical for Tactical Trading
Leans bearishJul 20
MIRM5806400 Bond Risk Profile
NeutralJul 16
US604749AB7 Bond Profile — Key Metrics
NeutralJul 16

JPMorgan Chase

Q1 2026 13F

$8.0M

position

HJ

Howe Jolanda

SVP, Global Controller · Cluster · Jul 2

$327K

sold

PC

Peetz Christopher

Chief Executive Officer · Cluster · Jun 2

$2.9M

sold

RS

Ramasastry Saira

Dir · Cluster · Jun 2

$398K

sold